Mentioned On
Episode Mentions
The Daily · May 17, 2026
Can We Reverse Aging?
“David Sinclair's biotech company with FDA approval for human trials using cellular rejuvenation to treat glaucoma and other eye diseases”
Moonshots with Peter Diamandis · Apr 28, 2026
David Sinclair: The GLP-1 Side Effect No One Talks About, What AI Found in His Lab, and Reversing Blindness | Q&A EP #251
“Company developing ER100 therapy for reversing age-related diseases including macular degeneration and blindness”
Moonshots with Peter Diamandis · Apr 27, 2026
David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250
“Company developing OSK gene therapy for epigenetic reprogramming; leading first human clinical trial for blindness cure”
All-In with Chamath, Jason, Sacks & Friedberg · Feb 28, 2026
Software Stocks Implode, Claude's Hit List, State of the Union Reactions, Trump's Tariff Pivot
“First company approved by FDA to test Yamanaka factors in humans for vision restoration”
The Human Upgrade: Biohacking for Longevity & Performance · Feb 6, 2026
Biohackers in the Epstein Files, Generic GLP-1s, Continuous Ketone Monitors, and more... : 1411
“Received FDA clearance for first-in-human gene therapy trial using Yamanaka factors to reverse aging in retinal cells”